ArticleCell research2020
IL-18: throwing off the shackles to boost anti-tumor immunity.
Article in Cell research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8Molecular therapy : the journal of the American Society of Gene Therapy · 2025Article
- Suppression of multiple mouse models of refractory malignancies by reprogramming IL-18 ligand-receptor interaction.Nature communications · 2025Article
- Immunotherapy in Head and Neck Cancer.Cancer treatment and research · 2025Review
- Discovery of indole analogue Tc3 as a potent pyroptosis inducer and identification of its combination strategy against hepatic carcinoma.Theranostics · 2025Article
- Cell-free DNA: plays an essential role in early diagnosis and immunotherapy of pancreatic cancer.Frontiers in immunology · 2025Review
- Durable antitumor response via an oncolytic virus encoding decoy-resistant IL-18.Journal for immunotherapy of cancer · 2024Article
- The dichotomic role of cytokines in aging.Biogerontology · 2024Review
- The intellectual base and research fronts of IL-18: A bibliometric review of the literature from WoSCC (2012-2022).Cell proliferation · 2024Review
- Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy.Current oncology reports · 2024Review
- Multi-scale geometric network analysis identifies melanoma immunotherapy response gene modules.Scientific reports · 2024Article
- Article
- Interleukin-18 Binding Protein in Immune Regulation and Autoimmune Diseases.Biomedicines · 2022Review
- Interleukins in cancer: from biology to therapy.Nature reviews. Cancer · 2021Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.